MESOBLAST LTD — Capital/Financing Update 2022

Aug 7, 2022

Market Announcement

==> picture [33 x 50] intentionally omitted <==

8 August 2022

==> picture [451 x 5] intentionally omitted <==

Mesoblast Limited (ASX: MSB) – Suspension from Quotation

Description

The securities of Mesoblast Limited (‘MSB’) will be suspended from quotation immediately under Listing Rule 17.2, at the request of MSB, pending the release of an announcement regarding a capital raising.

Issued by

Melissa Kostopoulos

Compliance Adviser, Listings Compliance (Melbourne)

Market Announcement 1/1 ASX Customer Service Centre 131 279 | asx.com.au

8 August 2022 ASX Limited

==> picture [177 x 23] intentionally omitted <==

8 August 2022

Ms Melissa Kostopoulos Adviser, Listings Compliance (Melbourne) ASX Compliance Pty Limited Level 4 Rialto North Tower 525 Collins Street Melbourne VIC 3000

Dear Melissa,

Request for voluntary suspension for Mesoblast Limited (ASX: MSB)

Pursuant to ASX Listing Rule 17.2, Mesoblast Limited ACN 109 431 870 (ASX: MSB; NASDAQ: MESO) (the Company ) requests that ASX grant a voluntary suspension in the trading of the Company's fully paid ordinary shares on the ASX effective prior to the commencement of trading today, 8 August 2022.

As the Company is still undergoing its capital raising, the Company is requesting a voluntary suspension from trading to allow it further time to complete that process, particularly given the global nature of the placement.

For the purposes of ASX Listing Rule 17.2, the Company provides the following information:

• (a) the voluntary suspension is requested to allow the Company further time to complete the capital raising as set out in its trading halt request dated Thursday, 4 August 2022, and to allow the capital raising to take place in an orderly fashion;

• (b) the Company requests that the voluntary suspension remain in place until the earlier of it making an announcement regarding the outcome of the capital raising and the commencement of trading on Wednesday, 10 August 2022;

• (c) the Company anticipates that the voluntary suspension will cease upon it announcing the outcome of the capital raising, which is expected to occur on or before Wednesday, 10 August 2022; and

• (d) the Company is not aware of any reason why the voluntary suspension should not be granted, or of any other information necessary to inform the market about the voluntary suspension.

==> picture [595 x 99] intentionally omitted <==

Yours sincerely

==> picture [84 x 60] intentionally omitted <==

Paul Hughes Joint Company Secretary Mesoblast Limited

ME_201203709_2